KALA BIO INC (KALA) Stock Income Statement
NASDAQ:KALA - Nasdaq - US4831192020 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 3.89M | 11.24M | |||
| Cost Of Goods | N/A | N/A | 0.00 | 2.56M | 4.10M | |||
| Gross Profit | N/A | N/A | 0.00 | 1.33M | 7.14M | |||
| Operating Expenses | 39.73M | 41.00M | 39.66M | 83.04M | 137.39M | |||
| Research and Development | 21.80M | N/A | 18.59M | 17.65M | 38.13M | |||
| Selling, General, and Administrative Expenses | 17.51M | 18.00M | 20.57M | 65.04M | 105.06M | |||
| Operating Income | -39.73M | -41.00M | -39.66M | -81.70M | -130.25M | |||
| Interest Income/Expense | -3.40M | N/A | -3.10M | -6.60M | -8.28M | |||
| Other Income/Expense | 7.47M | 2.00M | 567.00K | -930.00K | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | 44.41M | -4.08M | |||
| Income Before Taxes | -35.65M | -39.00M | -42.20M | -44.82M | -142.61M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -35.65M | -39.00M | -42.20M | -44.82M | -142.61M | |||
| EBITDA | -39.47M | -40.74M | -39.36M | -81.16M | -129.27M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -8.24 | -10.26 | -17.35 | -29.48 | -109.70 | |||
| Non GAAP EPS | -8.05 | -10.83 | -17.94 | -30.22 | -108.50 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | 34.19% | 63.52% | |||
| Profit Margin | N/A | N/A | N/A | -1152.19% | -1268.77% | |||
| Operating Profit Margin | N/A | N/A | N/A | -2100.26% | -1158.81% | |||
All data in USD